🇺🇸 FDA
Patent

US 11739294

Compositions and methods for treating retinal diseases

granted A61KA61K35/30A61K9/0019

Quick answer

US patent 11739294 (Compositions and methods for treating retinal diseases) held by The Regents of the University of California expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K35/30, A61K9/0019, A61K9/0048, A61P